Literature DB >> 12718555

Systematic and quantitative analysis of protein-protein recognition between nonribosomal peptide synthetases investigated in the tyrocidine biosynthetic template.

Uwe Linne1, Daniel B Stein, Henning D Mootz, Mohamed A Marahiel.   

Abstract

We present a systematic and quantitative study of the protein-protein recognition between the three tyrocidine synthetases TycA, TycB, and TycC investigated with two artificial in trans assay systems, which had been previously developed: the "DKP assay system" for the interaction of TycA with TycB and the "L/D-Phe-L-Asn assay system" for the interaction of TycB with TycC. TycA-A(Phe)TE and TycB(3)-A(Phe)TE, which are used as donor enzymes, both provide D-Phe-S-Ppant, so that no substrate specificities interfered with the quantification of protein-protein recognition. We tested all donor/acceptor enzyme combinations between the two artificial assay systems for product formation activities as well as two hybrid enzymes, where the E-domains of TycA and TycB(3) had been exchanged against each other. Furthermore, four donor/acceptor protein fusions were constructed on gene level, resulting in dimodular proteins. We were able to show that the E-domains mediate protein-protein recognition in trans. Product formation of the different donor assayed with the two acceptor enzymes TycB(1)-CA(Pro)T and TycC(1)-CA(Asn)T/Te in trans was only obtained if the donor enzyme harbored the cognate E-domain. Interestingly, all in cis fusions (dimodular proteins) were active, giving strong evidence that unnatural protein-protein interactions can be "forced" by fusion of the distinct enzymes. Finally, we were able to detect product formation in the "DKP system" with engineered hybrid proteins where the A-domain of TycA had been exchanged against the isoleucine-activating A-domain of BacA(1) and the valine-activating A-domain of TycC(4), respectively. All of these findings are of high relevance for future NRPS engineering approaches.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718555     DOI: 10.1021/bi034223o

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  Explorations of catalytic domains in non-ribosomal peptide synthetase enzymology.

Authors:  Gene H Hur; Christopher R Vickery; Michael D Burkart
Journal:  Nat Prod Rep       Date:  2012-07-17       Impact factor: 13.423

2.  Selective interaction between nonribosomal peptide synthetases is facilitated by short communication-mediating domains.

Authors:  Martin Hahn; Torsten Stachelhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-21       Impact factor: 11.205

3.  Protein-protein recognition between acyltransferases and acyl carrier proteins in multimodular polyketide synthases.

Authors:  Fong T Wong; Alice Y Chen; David E Cane; Chaitan Khosla
Journal:  Biochemistry       Date:  2010-01-12       Impact factor: 3.162

4.  In vivo production of artificial nonribosomal peptide products in the heterologous host Escherichia coli.

Authors:  Stephan Gruenewald; Henning D Mootz; Per Stehmeier; Torsten Stachelhaus
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

5.  SPLICEFINDER - a fast and easy screening method for active protein trans-splicing positions.

Authors:  Joachim Zettler; Simone Eppmann; Alena Busche; Dina Dikovskaya; Volker Dötsch; Henning D Mootz; Tim Sonntag
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

6.  Biocombinatorial Synthesis of Novel Lipopeptides by COM Domain-Mediated Reprogramming of the Plipastatin NRPS Complex.

Authors:  Hongxia Liu; Ling Gao; Jinzhi Han; Zhi Ma; Zhaoxin Lu; Chen Dai; Chong Zhang; Xiaomei Bie
Journal:  Front Microbiol       Date:  2016-11-17       Impact factor: 5.640

7.  Bacillibactin and Bacillomycin Analogues with Cytotoxicities against Human Cancer Cell Lines from Marine Bacillus sp. PKU-MA00093 and PKU-MA00092.

Authors:  Mengjie Zhou; Fawang Liu; Xiaoyan Yang; Jing Jin; Xin Dong; Ke-Wu Zeng; Dong Liu; Yingtao Zhang; Ming Ma; Donghui Yang
Journal:  Mar Drugs       Date:  2018-01-10       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.